Go to
JCI Insight
Citations to this article
Max R. O’Donnell, … , Andrew Eisenberger, Walter I. Lipkin
Published May 11, 2021
Citation Information: J Clin Invest. 2021;131(13):e150646. https://doi.org/10.1172/JCI150646.
Citation Information: J Clin Invest. 2021;131(13):e150646. https://doi.org/10.1172/JCI150646.
Abstract
BACKGROUND Although convalescent plasma has been widely used to treat severe coronavirus disease 2019 (COVID-19), data from randomized controlled trials that support its efficacy are limited.METHODS We conducted a randomized, double-blind, controlled trial among adults hospitalized with severe and critical COVID-19 at 5 sites in New York City (USA) and Rio de Janeiro (Brazil). Patients were randomized 2:1 to receive a single transfusion of either convalescent plasma or normal control plasma. The primary outcome was clinical status at 28 days following randomization, measured using an ordinal scale and analyzed using a proportional odds model in the intention-to-treat population.RESULTS Of 223 participants enrolled, 150 were randomized to receive convalescent plasma and 73 to receive normal control plasma. At 28 days, no significant improvement in the clinical scale was observed in participants randomized to convalescent plasma (OR 1.50, 95% confidence interval [CI] 0.83–2.68, P = 0.180). However, 28-day mortality was significantly lower in participants randomized to convalescent plasma versus control plasma (19/150 [12.6%] versus 18/73 [24.6%], OR 0.44, 95% CI 0.22–0.91, P = 0.034). The median titer of anti–SARS-CoV-2 neutralizing antibody in infused convalescent plasma units was 1:160 (IQR 1:80–1:320). In a subset of nasopharyngeal swab samples from Brazil that underwent genomic sequencing, no evidence of neutralization-escape mutants was detected.CONCLUSION In adults hospitalized with severe COVID-19, use of convalescent plasma was not associated with significant improvement in day 28 clinical status. However, convalescent plasma was associated with significantly improved survival. A possible explanation is that survivors remained hospitalized at their baseline clinical status.TRIAL REGISTRATION ClinicalTrials.gov, NCT04359810.FUNDING Amazon Foundation, Skoll Foundation.
Authors
Max R. O’Donnell, Beatriz Grinsztejn, Matthew J. Cummings, Jessica E. Justman, Matthew R. Lamb, Christina M. Eckhardt, Neena M. Philip, Ying Kuen Cheung, Vinay Gupta, Esau João, Jose Henrique Pilotto, Maria Pia Diniz, Sandra Wagner Cardoso, Darryl Abrams, Kartik N. Rajagopalan, Sarah E. Borden, Allison Wolf, Leon Claude Sidi, Alexandre Vizzoni, Valdilea G. Veloso, Zachary C. Bitan, Dawn E. Scotto, Benjamin J. Meyer, Samuel D. Jacobson, Alex Kantor, Nischay Mishra, Lokendra V. Chauhan, Elizabeth F. Stone, Flavia Dei Zotti, Francesca La Carpia, Krystalyn E. Hudson, Stephen A. Ferrara, Joseph Schwartz, Brie A. Stotler, Wen-Hsuan W. Lin, Sandeep N. Wontakal, Beth Shaz, Thomas Briese, Eldad A. Hod, Steven L. Spitalnik, Andrew Eisenberger, Walter I. Lipkin
Citation information
Citations to this article (114)
| Title and authors | Publication | Year |
|---|---|---|
|
A Rapid Systematic Review of U.S. Food and Drug Administration-Authorized COVID-19 Treatments
Maglione MA, Klausner JD, Wirnkar PK, Fallarme I, Lak R, Sysawang K, Fu N, Yagyu S, Motala A, Tolentino D, Hempel S |
Open Forum Infectious Diseases | 2025 |
|
Association between COVID-19 convalescent plasma antibody levels and COVID-19 outcomes stratified by clinical status at presentation
Park H, Yu C, Pirofski LA, Yoon H, Wu D, Li Y, Tarpey T, Petkova E, Antman EM, Troxel AB |
BMC Infectious Diseases | 2024 |
|
Exploring Study Design Foibles in Randomized Controlled Trials on Convalescent Plasma in Hospitalized COVID-19 Patients
Franchini M, Mengoli C, Casadevall A, Focosi D |
Life Sciences | 2024 |
|
The effect of convalescent plasma therapy on the rate of nucleic acid negative conversion in patients with persistent COVID-19 test positivity
Wang Y, Xu Z, Xu X, Yang S, Li Y, Zhang H, Zhang Y, Wang FS, Wang Y, Bi J |
Frontiers in Pharmacology | 2024 |
|
Characterization of therapeutic antibodies efficacy against multiple SARS-CoV-2 variants in the hamster model
Cong Y, Dixit S, Perry DL, Huzella LM, Kollins E, Byrum R, Anthony SM, Drawbaugh D, Lembirik S, Postnikova E, Eaton B, Murphy M, Kocher G, Hadley K, Marketon AE, Bernbaum RM, Hischak AM, Hart R, Vaughan N, Wada J, Qin J, St. Claire MC, Schmaljohn CS, Holbrook MR |
Antiviral research | 2024 |
|
COVID-19 convalescent plasma boosts early antibody titer and does not influence the adaptive immune response
John McDyer, Mahzad Azimpouran, Valerie Durkalski-Mauldin, Robert Clevenger, Sharon Yeatts, Xutao Deng, William Barsan, Robert Silbergleit, Nahed Kassar, Iulia Popescu, Dimiter Dimitrov, Wei Li, Emily Lyons, Sophia Lieber, Mars Stone, Frederick Korley, Clifton Callaway, Larry Dumont, Philip Norris |
JCI Insight | 2023 |
|
Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update
Chavda VP, Bezbaruah R, Dolia S, Shah N, Verma S, Savale S, Ray S |
2023 | |
|
Convalescent plasma for people with COVID‐19: a living systematic review
Iannizzi C, Chai KL, Piechotta V, Valk SJ, Kimber C, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Jindal A, Cryns N, Estcourt LJ, Kreuzberger N, Skoetz N |
The Cochrane Database of Systematic Reviews | 2023 |
|
Effect of convalescent plasma transfusion on outcomes of coronavirus disease 2019: a meta-analysis with trial sequential analysis
Hakim SM, Chikhouni GM, Ammar MA, Amer AM |
Journal of Anesthesia | 2023 |
|
Convalescent Plasma Therapy for COVID-19: A Systematic Review and Meta-Analysis on Randomized Controlled Trials
Filippatos C, Ntanasis-Stathopoulos I, Sekeri K, Ntanasis-Stathopoulos A, Gavriatopoulou M, Psaltopoulou T, Dounias G, Sergentanis TN, Terpos E |
Viruses | 2023 |
|
Evaluation of a panel of therapeutic antibody clinical candidates for efficacy against SARS-CoV-2 in Syrian hamsters.
Cong Y, Mucker EM, Perry DL, Dixit S, Kollins E, Byrum R, Huzella L, Kim R, Josleyn M, Kwilas S, Stefan C, Shoemaker CJ, Koehler J, Coyne S, Delp K, Liang J, Drawbaugh D, Hischak A, Hart R, Postnikova E, Vaughan N, Asher J, St Claire M, Hanson J, Schmaljohn C, Eakin AE, Hooper JW, Holbrook MR |
Antiviral Research | 2023 |
|
High-Throughput Neutralization and Serology Assays Reveal Correlated but Highly Variable Humoral Immune Responses in a Large Population of Individuals Infected with SARS-CoV-2 in the US between March and August 2020
Zhang S, Ma P, Orzechowski M, Lemmer A, Rzasa K, Bagnall J, Barkho S, Chen M, He L, Neitupski R, Tran V, Ackerman R, Gath E, Bond A, Frongillo G, Cleland T, Golas A, Gaca A, Fitzgerald M, Kelly K, Hazegh K, Dumont L, Hoffman C, Homer M, Marks P, Woolley A, Wong S, Gomez J, Livny J, Hung D |
mBio | 2023 |
|
Reduced Mortality among COVID-19 ICU Patients after Treatment with HemoClear Convalescent Plasma in Suriname
Bihariesingh-Sanchit R, Bansie R, Ramdhani N, Mangroo R, Bustamente D, Diaz E, Fung A Foek C, Thakoer I, Vreden S, Choudhry Z, van \u2018t Wout AB, Diavatopoulos DA, Nierich AP |
mBio | 2023 |
|
Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19 (COVIC-19): protocol for a randomised, open-label trial
Desmarets M, Hoffmann S, Vauchy C, Rijnders BJ, Toussirot E, Durrbach A, Körper S, Schrezenmeier E, van der Schoot CE, Harvala H, Brunotte G, Appl T, Seifried E, Tiberghien P, Bradshaw D, Roberts DJ, Estcourt LJ, Schrezenmeier H |
BMJ Open | 2023 |
|
Clinical application of SARS-CoV-2 antibody detection and monoclonal antibody therapies against COVID-19
Sun J, Yang ZD, Xie X, Li L, Zeng HS, Gong B, Xu JQ, Wu JH, Qu BB, Song GW |
World journal of clinical cases | 2023 |
|
SARS-CoV-2 vaccination of convalescents boosts neutralization capacity against Omicron subvariants BA.1, BA.2 and BA.5 and can be predicted by anti-S antibody concentrations in serological assays
Seidel A, Hoffmann S, Jahrsdörfer B, Körper S, Ludwig C, Vieweg C, Albers D, von Maltitz P, Müller R, Lotfi R, Wuchter P, Klüter H, Kirchhoff F, Schmidt M, Münch J, Schrezenmeier H |
Frontiers in immunology | 2023 |
|
Convalescent plasma for people with COVID‐19: a living systematic review
Iannizzi C, Chai KL, Piechotta V, Valk SJ, Kimber C, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Jindal A, Cryns N, Estcourt LJ, Kreuzberger N, Skoetz N |
The Cochrane Database of Systematic Reviews | 2023 |
|
Convalescent plasma and all-cause mortality of COVID-19 patients: systematic review and meta-analysis.
Mihalek N, Radovanović D, Barak O, Čolović P, Huber M, Erdoes G |
Scientific Reports | 2023 |
|
Pathophysiology and clinical management of coronavirus disease (COVID-19): a mini-review.
Zhu Y, Sharma L, Chang D |
Frontiers in immunology | 2023 |
|
Rates Among Hospitalized Patients With COVID-19 Treated With Convalescent Plasma: A Systematic Review and Meta-Analysis
Senefeld JW, Gorman EK, Johnson PW, Moir ME, Klassen SA, Carter RE, Paneth NS, Sullivan DJ, Morkeberg OH, Wright RS, Fairweather D, Bruno KA, Shoham S, Bloch EM, Focosi D, Henderson JP, Juskewitch JE, Pirofski LA, Grossman BJ, Tobian AA, Franchini M, Ganesh R, Hurt RT, Kay NE, Parikh SA, Baker SE, Buchholtz ZA, Buras MR, Clayburn AJ, Dennis JJ, Diaz Soto JC, Herasevich V, Klompas AM, Kunze KL, Larson KF, Mills JR, Regimbal RJ, Ripoll JG, Sexton MA, Shepherd JR, Stubbs JR, Theel ES, van Buskirk CM, van Helmond N, Vogt MN, Whelan ER, Wiggins CC, Winters JL, Casadevall A, Joyner MJ |
2023 | |
|
Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial
Lacombe K, Hueso T, Porcher R, Mekinian A, Chiarabini T, Georgin-Lavialle S, Ader F, Saison J, Martin-Blondel G, De Castro N, Bonnet F, Cazanave C, Francois A, Morel P, Hermine O, Pourcher V, Michel M, Lescure X, Soussi N, Brun P, Pommeret F, Sellier P, Rousset S, Piroth L, Michot JM, Baron G, de Lamballerie X, Mariette X, Tharaux PL, Resche-Rigon M, Ravaud P, Simon T, Tiberghien P |
2023 | |
|
Blood‐derived product therapies for SARS‐CoV‐2 infection and long COVID
Wu J, Yang H, Yu D, Yang X |
2023 | |
|
The impact of early anti-SARS-CoV-2 antibody production on the length of hospitalization stay among COVID-19 patients
de Almeida DV, Cezar PA, Fernandes TF, Schwarz MG, Mendonça-Lima L, Giacoia-Gripp CB, Côrtes FH, Lindenmeyer Guimarães M, Pilotto JH, De Sá NB, Cazote AD, Gomes LR, Quintana MD, Ribeiro-Alves M, Coelho LE, Geraldo KM, Ribeiro MP, Cardoso SW, Grinsztejn B, Veloso VG, Morgado MG |
Microbiology spectrum | 2023 |
|
The II Brazilian Guidelines for the pharmacological treatment of patients hospitalized with COVID-19 Joint Guidelines of the Associação Brasileira de Medicina de Emergência, Associação de Medicina Intensiva Brasileira, Associação Médica Brasileira, Sociedade Brasileira de Angiologia e Cirurgia Vascular, Sociedade Brasileira de Infectologia, Sociedade Brasileira de Pneumologia e Tisiologia and Sociedade Brasileira de Reumatologia.
Falavigna M, Araujo CLP, Barbosa AN, Belli KC, Colpani V, Dal-Pizzol F, Silva RMD, Azevedo LCP, Dias MBS, Amaral JLGD, Dorneles GP, Ferreira JC, Freitas APDR, Gräf DD, Guimarães HP, Lobo SMA, Machado FR, Nunes MS, Oliveira MS, Parahiba SM, Rosa RG, Santos VCC, Sobreira ML, Veiga VC, Xavier RM, Zavascki AP, Stein C, Carvalho CRR |
2023 | |
|
Convalescent Plasma for Covid-19–Induced ARDS in Mechanically Ventilated Patients
Misset B, Piagnerelli M, Hoste E, Dardenne N, Grimaldi D, Michaux I, De Waele E, Dumoulin A, Jorens PG, van der Hauwaert E, Vallot F, Lamote S, Swinnen W, De Schryver N, Fraipont V, de Mey N, Dauby N, Layios N, Mesland JB, Meyfroidt G, Moutschen M, Compernolle V, Gothot A, Desmecht D, Taveira da Silva Pereira MI, Garigliany M, Najdovski T, Bertrand A, Donneau AF, Laterre PF |
The New England journal of medicine | 2023 |
|
Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response
Maddalena Marconato, Irene A Abela, Anthony Hauser, Magdalena Schwarzmüller, Rheliana Katzensteiner, Dominique L. Braun, Selina Epp, Annette Audigé, Jacqueline Weber, Peter Rusert, Emèry Schindler, Chloé Pasin, Emily West, Jürg Böni, Verena Kufner, Michael Huber, Maryam Zaheri, Stefan Schmutz, Beat M. Frey, Roger D. Kouyos, Huldrych Günthard, Markus G. Manz, Alexandra Trkola |
Journal of Clinical Investigation | 2022 |
|
Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-19: a longitudinal cohort and propensity score analysis
T Hueso, A Godron, E Lanoy, J Pacanowski, L Levi, E Gras, L Surgers, A Guemriche, J Meynard, F Pirenne, S Idri, P Tiberghien, P Morel, C Besson, R Duléry, S Lamure, O Hermine, A Gagneux-Brunon, N Freymond, S Grabar, K Lacombe |
Leukemia | 2022 |
|
Multi-center matched cohort study of convalescent plasma for hospitalized patients with COVID-19
Cindy Ke Zhou, Monica M Bennett, Carlos H Villa, Kendall Hammonds, Yun Lu, Jason Ettlinger, Elisa Priest, Robert Gottlieb, Steven Davis, Edward Mays, Tainya C Clarke, Azadeh Shoaibi, Hui-Lee Wong, Steven A Anderson, Ronan Kelly |
PloS one | 2022 |
|
Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2
H Natarajan, S Xu, A Crowley, S Butler, J Weiner, E Bloch, K Littlefield, S Benner, R Shrestha, O Ajayi, W Wieland-Alter, D Sullivan, S Shoham, T Quinn, A Casadevall, A Pekosz, A Redd, A Tobian, R Connor, P Wright, M Ackerman |
BMC Immunology | 2022 |
|
Early Outpatient Treatment for Covid-19 with Convalescent Plasma
D Sullivan, K Gebo, S Shoham, E Bloch, B Lau, A Shenoy, G Mosnaim, T Gniadek, Y Fukuta, B Patel, S Heath, A Levine, B Meisenberg, E Spivak, S Anjan, M Huaman, J Blair, J Currier, J Paxton, J Gerber, J Petrini, P Broderick, W Rausch, M Cordisco, J Hammel, B Greenblatt, V Cluzet, D Cruser, K Oei, M Abinante, L Hammitt, C Sutcliffe, D Forthal, M Zand, E Cachay, J Raval, S Kassaye, E Foster, M Roth, C Marshall, A Yarava, K Lane, N McBee, A Gawad, N Karlen, A Singh, D Ford, D Jabs, L Appel, D Shade, S Ehrhardt, S Baksh, O Laeyendecker, A Pekosz, S Klein, A Casadevall, A Tobian, D Hanley |
New England Journal of Medicine | 2022 |
|
Lessons learned from the use of convalescent plasma for the treatment of COVID-19 and specific considerations for immunocompromised patients
M Beraud, E Meyer, M Lozano, A Bah, R Vassallo, B Brown |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2022 |
|
A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19
Y Ray, S Paul, P Bandopadhyay, R DRozario, J Sarif, D Raychaudhuri, D Bhowmik, A Lahiri, J Vasudevan, R Maurya, A Kanakan, S Sharma, M Kumar, P Singh, R Roy, K Chaudhury, R Maiti, S Bagchi, A Maiti, M Perwez, A Mondal, A Tewari, S Mandal, A Roy, M Saha, D Biswas, C Maiti, R Bhaduri, S Chakraborty, B Sarkar, A Haldar, B Saha, S Sengupta, R Pandey, S Chatterjee, P Bhattacharya, S Paul, D Ganguly |
Nature Communications | 2022 |
|
High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial
A Alemany, P Millat-Martinez, M Corbacho-Monné, P Malchair, D Ouchi, A Ruiz-Comellas, A Ramírez-Morros, J Codina, R Simon, S Videla, G Costes, M Capdevila-Jáuregui, P Torrano-Soler, A José, G Papell, J Puig, A Otero, J Suarez, A Pellejero, F Roca, O Cortez, V Garcia, J Vidal-Alaball, A Millan, E Contreras, J Grifols, À Ancochea, I Galvan-Femenia, F Ferreira, M Bonet, J Cantoni, N Prat, J Ara, A Arcarons, M Farré, E Pradenas, J Blanco, M Rodriguez-Arias, G Rivas, M Marks, Q Bassat, I Blanco, B Baro, B Clotet, O Mitjà, S Ferrer, M Gallardo, M Ubals, C González-Beiras, M Vall-Mayans, C Suñer, C Laporte-Villar, A Nieto, X Comas-Leon, Z Jiménez, F Ramírez-Viaplana, M Delgado-Capel, B Sánchez, M Barber, C Ruiz, L Gonzalez, D García, A Larraza, V Peiró, C López, N Robert, C Palet, C Gudiol, P Gonzalez, G Vila, B Aguilera, G Rodríguez-Sevilla, M Arias, J Font, K Matos, G Valmaña, C Obradors, S García, M Sabatès, R Rodríguez, R Línio, M Fornos, N Casamitjana, E Alonso, N Martínez, L Maglio, L Fernandez, N Garcia, L Hernández, M González, A Bravo, Y García, S Oliveras, T Vertiz, S Benavent, A Bianco, J Verdaguer, N Zambrano, M Meya, Á Hernández, C Lopez, A Bordoy, V Soler, M Giménez, A París, S Marfil, B Trinité, E Grau |
The lancet. Respiratory medicine | 2022 |
|
Timing of convalescent plasma administration and 28-day mortality in COVID-19 pneumonia
S González, L Regairaz, M Salazar, N Ferrando, V Martínez, P Ramos, S Pesci, J Vidal, N Kreplak, E Estenssoro |
Journal of Investigative Medicine | 2022 |
|
Convalescent plasma in the treatment of moderate to severe COVID-19 pneumonia: a randomized controlled trial (PROTECT-Patient Trial)
K van den Berg, T Glatt, M Vermeulen, F Little, R Swanevelder, C Barrett, R Court, M Bremer, C Nyoni, A Swarts, C Mmenu, T Crede, G Kritzinger, J Naude, P Szymanski, J Cowley, T Moyo-Gwete, P Moore, J Black, J Singh, J Bhiman, P Baijnath, P Mody, J Malherbe, S Potgieter, C van Vuuren, S Maasdorp, R Wilkinson, V Louw, S Wasserman |
Scientific Reports | 2022 |
|
Convalescent plasma may not be an effective treatment for severe and critically ill covid-19 patients: A Systematic Review & Meta-Analysis of Randomized Controlled Trials
P Yang, J Wang, R Zheng, R Tan, X Li, X Liu, Y Li, Z Yuan, Y Wang, Q Chen, J Yu |
Heart & lung : the journal of critical care | 2022 |
|
Convalescent Plasma Treatment in Patients with Covid-19: A Systematic Review and Meta-Analysis
A Jorda, M Kussmann, N Kolenchery, J Siller-Matula, M Zeitlinger, B Jilma, G Gelbenegger |
Frontiers in immunology | 2022 |
|
High-Dose Convalescent Plasma for Treatment of Severe COVID-19
G Santis, L Oliveira, P Garibaldi, C Almado, J Croda, G Arcanjo, É Oliveira, A Tonacio, D Langhi, J Bordin, R Gilio, L Palma, E Santos, S Haddad, B Prado, M Pontelli, R Gomes, C Miranda, M Martins, D Covas, E Arruda, B Fonseca, R Calado |
Emerging infectious diseases | 2022 |
|
Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI)
A Song, V Rocha, A Mendrone-Júnior, R Calado, G Santis, B Benites, C Costa-Lima, T Vargas, L Marques, J Fernandes, F Breda, S Wendel, R Fachini, L Rizzo, J Kutner, V Avelino-Silva, R Machado, E Durigon, S Chevret, E Kallas |
2022 | |
|
CD24Fc: an emerging COVID-19 therapy
C Eckhardt, M O'Donnell |
The Lancet Infectious Diseases | 2022 |
|
Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants
W Strohl, Z Ku, Z An, S Carroll, B Keyt, L Strohl |
BioDrugs | 2022 |
|
Early administration of COVID ‐19 convalescent plasma with high titer antibody content by live viral neutralization assay is associated with modest clinical efficacy
A Belov, Y Huang, C Villa, B Whitaker, R Forshee, S Anderson, A Eder, N Verdun, M Joyner, S Wright, R Carter, D Hung, M Homer, C Hoffman, M Lauer, P Marks |
American Journal of Hematology | 2022 |
|
Efficacy of early transfusion of convalescent plasma with high‐titer SARS‐CoV ‐2 neutralizing antibodies in hospitalized patients with COVID ‐19
C Sanz, M Nomdedeu, A Pereira, S Sauleda, R Alonso, M Bes, H Brillembourg, C GarcíaVidal, A Millan, N MartínezLlonch, M Pirón, P PuertaAlcalde, L Puig, V Rico, A Soriano |
Transfusion | 2022 |
|
Human Identical Sequences, hyaluronan, and hymecromone ─ the new mechanism and management of COVID-19
S Yang, Y Tong, L Chen, W Yu |
2022 | |
|
Evaluation of Antibody-Dependent Fc-Mediated Viral Entry, as Compared With Neutralization, in SARS-CoV-2 Infection
Wieczorek L, Zemil M, Merbah M, Dussupt V, Kavusak E, Molnar S, Heller J, Beckman B, Wollen-Roberts S, Peachman KK, Darden JM, Krebs S, Rolland M, Peel SA, Polonis VR |
Frontiers in immunology | 2022 |
|
Prospective individual patient data meta-analysis of two randomized trials on convalescent plasma for COVID-19 outpatients
Millat-Martinez P, Gharbharan A, Alemany A, Rokx C, Geurtsvankessel C, Papageourgiou G, van Geloven N, Jordans C, Groeneveld G, Swaneveld F, van der Schoot E, Corbacho-Monné M, Ouchi D, Piccolo Ferreira F, Malchair P, Videla S, García García V, Ruiz-Comellas A, Ramírez-Morros A, Rodriguez Codina J, Amado Simon R, Grifols JR, Blanco J, Blanco I, Ara J, Bassat Q, Clotet B, Baro B, Troxel A, Zwaginga JJ, Mitjà O, Rijnders BJ |
Nature Communications | 2022 |
|
Differential efficacy and safety of anti-SARS-CoV-2 antibody therapies for the management of COVID-19: a systematic review and network meta-analysis
Deng J, Heybati K, Ramaraju HB, Zhou F, Rayner D, Heybati S |
Infection | 2022 |
|
Long-term outcome after COVID-19 convalescent plasma treatment in patients with severe COVID-19: One year follow up of the randomized clinical trial CAPSID
Sixten Körper, Beate Grüner, Daniel Zickler, Thomas Wiesmann, Patrick Wuchter, Rainer Blasczyk, Kai Zacharowski, Peter Spieth, Torsten Tonn, Peter Rosenberger, Gregor Paul, Jan Pilch, Joachim Schwäble, Tamam Bakchoul, Thomas Thiele, Julian Knörlein, Matthias Dollinger, Jörg Krebs, Martin Bentz, Victor Corman, Dzenan Kilalic, Gerlinde Schmidtke-Schrezenmeier, Philipp Lepper, Lucas Ernst, Hinnerk Wulf, Alexandra Ulrich, Manfred Weiss, Jan Kruse, Thomas Burkhardt, Rebecca Müller, Harald Klüter, Bernd Jahrsdörfer, Ramin Lotfi, Markus Rojewski, Thomas Appl, Benjamin Mayer, Philipp Schnecko, Erhard Seifried, Hubert Schrezenmeier |
Journal of Clinical Investigation | 2022 |
|
Awaiting a cure for COVID-19: therapeutic approach in patients with different severity levels of COVID-19
Alfano G, Morisi N, Frisina M, Ferrari A, Fontana F, Tonelli R, Franceschini E, Meschiari M, Donati G, Guaraldi G |
Le infezioni in medicina | 2022 |
|
Efficacy and Safety of Blood Derivative Therapy for Patients with COVID-19: A Systematic Review and Meta-Analysis
Fei Z, Chen Z, Du X, Cao H, Li C |
Transfusion Medicine and Hemotherapy | 2022 |
|
Rethinking the role of COVID-19 convalescent plasma in the critically ill.
Casadevall A, Pirofski LA |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2022 |
|
Predictors of mortality in COVID-19 patients treated with convalescent plasma therapy
Rahimi-Levene N, Shapira J, Tzur I, Shiloah E, Peer V, Levin E, Izak M, Shinar E, Ziv-Baran T, Weinberger M, Zimhony O, Chen J, Maor Y |
PloS one | 2022 |
|
Brazilian Guidelines for the pharmacological treatment of patients hospitalized with COVID-19: Joint guideline of Associação Brasileira de Medicina de Emergência, Associação de Medicina Intensiva Brasileira, Associação Médica Brasileira, Sociedade Brasileira de Angiologia e Cirurgia Vascular, Sociedade Brasileira de Infectologia, Sociedade Brasileira de Pneumologia e Tisiologia, Sociedade Brasileira de Reumatologia.
Falavigna M, Stein C, Amaral JLGD, Azevedo LCP, Belli KC, Colpani V, Cunha CAD, Dal-Pizzol F, Dias MBS, Ferreira JC, Freitas APDR, Gräf DD, Guimarães HP, Lobo SMA, Monteiro JT, Nunes MS, Oliveira MS, Prado CCL, Santos VCC, Silva RMD, Sobreira ML, Veiga VC, Vidal ÁT, Xavier RM, Zavascki AP, Machado FR, Carvalho CRR |
Revista Brasileira de Terapia Intensiva | 2022 |
|
Decrease in Angiotensin-Converting Enzyme activity but not concentration in plasma/lungs in COVID-19 patients offers clues for diagnosis/treatment.
Daniell H, Nair SK, Shi Y, Wang P, Montone KT, Shaw PA, Choi GH, Ghani D, Weaver J, Rader DJ, Margulies KB, Collman RG, Laudanski K, Bar KJ |
2022 | |
|
Brazilian Guidelines for the pharmacological treatment of patients hospitalized with COVID-19 Joint guideline of Associação Brasileira de Medicina de Emergência, Associação de Medicina Intensiva Brasileira, Associação Médica Brasileira, Sociedade Brasileira de Angiologia e Cirurgia Vascular, Sociedade Brasileira de Infectologia, Sociedade Brasileira de Pneumologia e Tisiologia, Sociedade Brasileira de Reumatologia
Falavigna M, Stein C, do Amaral JL, de Azevedo LC, Belli KC, Colpani V, da Cunha CA, Dal-Pizzol F, Dias MB, Ferreira JC, Freitas AP, Gräf DD, Guimarães HP, Lobo SM, Monteiro JT, Nunes MS, de Oliveira MS, Prado CC, Santos VC, da Silva RM, Sobreira ML, Veiga VC, Vidal ÁT, Xavier RM, Zavascki AP, Machado FR, de Carvalho CR |
Revista Brasileira de Terapia Intensiva | 2022 |
|
The efficiency of convalescent plasma in COVID-19 patients: A systematic review and meta-analysis of randomized controlled clinical trials
Qian Z, Zhang Z, Ma H, Shao S, Kang H, Tong Z |
Frontiers in immunology | 2022 |
|
SARS-CoV-2 Antibody Longitudinal Profile of Immune Globulin Preparations.
Park HJ, Alcover KC, Wang Q, Gada SM |
2022 | |
|
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes
Focosi D, Franchini M, Pirofski LA, Burnouf T, Paneth N, Joyner MJ, Casadevall A |
Clinical microbiology reviews | 2022 |
|
Convalescent Plasma for COVID-19: A Single Center Prospective Experience with Serial Antibody Measurements and Review of the Literature
Whang SN, Shah VD, Pu L, Sheth P, Lucas GN, Lee J, Lee M, Lacy C, Duerksen-Hughes PJ, Filippov V, Lee DJ, Veltman J, Maken K, Reeves ME, Stevens WT, Herrmann P, Cao H, Lau E |
Pathogens | 2022 |
|
Efficacy and Safety of COVID-19 Treatment Using Convalescent Plasma Transfusion: Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
Lee HJ, Lee JH, Cho Y, Ngoc LT, Lee YC |
International journal of environmental research and public health | 2022 |
|
Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma
Estcourt LJ, Cohn CS, Pagano MB, Iannizzi C, Kreuzberger N, Skoetz N, Allen ES, Bloch EM, Beaudoin G, Casadevall A, Devine DV, Foroutan F, Gniadek TJ, Goel R, Gorlin J, Grossman BJ, Joyner MJ, Metcalf RA, Raval JS, Rice TW, Shaz BH, Vassallo RR, Winters JL, Tobian AA |
Annals of internal medicine | 2022 |
|
Convalescent plasma and COVID‐19: Time for a second—second look?
Joyner MJ, Carter RE, Fairweather D, Wright RS |
Transfusion Medicine | 2022 |
|
Efficacy and Safety of Convalescence Plasma Therapy in COVID-19 Patients: A Systematic Review and Meta-Analysis
Dai R, Hu M, Tang H, Peng Z, Yan C |
Evidence-based complementary and alternative medicine : eCAM | 2022 |
|
Cytokine levels associated with favorable clinical outcome in the CAPSID randomized trial of convalescent plasma in patients with severe COVID-19
Körper S, Schrezenmeier EV, Rincon-Arevalo H, Grüner B, Zickler D, Weiss M, Wiesmann T, Zacharowski K, Kalbhenn J, Bentz M, Dollinger MM, Paul G, Lepper PM, Ernst L, Wulf H, Zinn S, Appl T, Jahrsdörfer B, Rojewski M, Lotfi R, Dörner T, Jungwirth B, Seifried E, Fürst D, Schrezenmeier H |
Frontiers in immunology | 2022 |
|
Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study.
Bartelt LA, Markmann AJ, Nelson B, Keys J, Root H, Henderson HI, Kuruc J, Baker C, Bhowmik DR, Hou YJ, Premkumar L, Cornaby C, Schmitz JL, Weiss S, Park Y, Baric R, de Silva AM, Lachiewicz A, Napravnik S, van Duin D, Margolis DM |
mBio | 2022 |
|
Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients-An Open-Label Phase II Clinical Trial.
Grubovic Rastvorceva RM, Useini S, Stevanovic M, Demiri I, Petkovic E, Franchini M, Focosi D |
2022 | |
|
COVID-19 Convalescent Plasma and Concomitant Therapies in PassITON.
Casadevall A, Henderson JP |
Chest | 2022 |
|
Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapy
Herman JD, Wang C, Burke JS, Zur Y, Compere H, Kang J, Macvicar R, Taylor S, Shin S, Frank I, Siegel D, Tebas P, Choi GH, Shaw PA, Yoon H, Pirofski LA, Julg BD, Bar KJ, Lauffenburger D, Alter G |
Cell reports. Medicine | 2022 |
|
Use of convalescent plasma therapy in hospitalised adult patients with non-critical COVID-19: a focus on the elderly from Hungary
Kiss-Dala N, Szabo BG, Lakatos B, Reti M, Szlavik J, Valyi-Nagy I |
GeroScience | 2022 |
|
Therapeutic Strategies in the Fight against COVID-19: From Bench to Bedside
Abadi B, Aarabi Jeshvaghani AH, Fathalipour H, Dehghan L, Rahimi Sirjani K, Forootanfar H |
Iranian journal of medical sciences | 2022 |
|
The clinical outcomes of high neutralizing antibodies titer convalescent plasma therapy in early developed severe COVID-19 patients; a case-control study.
Nontawong N, Siripongboonsitti T, Tawinprai K, Boonpratoom M, Krailassiri N, Boonkhum C, Soonklang K, Poovorawan Y, Mahanonda N |
Annals of clinical microbiology and antimicrobials | 2022 |
|
Convalescent or standard plasma versus standard of care in the treatment of COVID-19 patients with respiratory impairment: short and long-term effects. A three-arm randomized controlled clinical trial
Manzini PM, Ciccone G, De Rosa FG, Cavallo R, Ghisetti V, D\u2019Antico S, Galassi C, Saccona F, Castiglione A, Birocco N, Francisci T, Hu H, Pecoraro C, Danielle F, Labanca L, Bordiga AM, Lorenzi M, Camisasca G, Giachino O, Pagliarino M, Ottone P, Scuvera IT, Guaschino R, Freilone R, Berti P, Pittaluga F, Avolio M, Costa C, Raso S, Nucci A, Milan M, Baffa A, Russo A, Tornello A, Maddalena L, Delios G, Marletto FP, De Micheli AG, Mattei A, Baldassano S, Canta F, Russo ML, Bergamo D, Vitale F, Liccardi MM, Chinaglia A, Calcagno A, Converso M, Aldieri C, Libanore V, Blangetti I, Benedetti V, Mitola B, Scozzari G |
BMC Infectious Diseases | 2022 |
|
Inflammatory markers and auto-Abs to type I IFNs in COVID-19 convalescent plasma cohort study
Cognasse F, Hamzeh-Cognasse H, Rosa M, Corseaux D, Bonneaudeau B, Pierre C, Huet J, Arthaud CA, Eyraud MA, Prier A, Duchez AC, Ebermeyer T, Heestermans M, Audoux-Caire E, Philippot Q, Le Voyer T, Hequet O, Fillet AM, Chavarin P, Legrand D, Richard P, Pirenne F, Gallian P, Casanova JL, Susen S, Morel P, Lacombe K, Bastard P, Tiberghien P |
EBioMedicine | 2022 |
|
Understanding the challenges to COVID-19 vaccines and treatment options, herd immunity and probability of reinfection
Al-Hatamleh MA, Abusalah MA, Hatmal MM, Alshaer W, Ahmad S, Mohd-Zahid MH, Rahman EN, Yean CY, Alias IZ, Uskoković V, Mohamud R |
Journal of Taibah University Medical Sciences | 2022 |
|
Absence of pathogenic viruses in COVID-19 convalescent plasma.
Kandathil AJ, Benner SE, Bloch EM, Shrestha R, Ajayi O, Zhu X, Caturegli PP, Shoham S, Sullivan D, Gebo K, Quinn TC, Casadevall A, Hanley D, Pekosz A, Redd AD, Balagopal A, Tobian AAR |
Transfusion | 2022 |
|
Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial
Denkinger CM, Janssen M, Schäkel U, Gall J, Leo A, Stelmach P, Weber SF, Krisam J, Baumann L, Stermann J, Merle U, Weigand MA, Nusshag C, Bullinger L, Schrezenmeier JF, Bornhäuser M, Alakel N, Witzke O, Wolf T, Vehreschild MJ, Schmiedel S, Addo MM, Herth F, Kreuter M, Tepasse PR, Hertenstein B, Hänel M, Morgner A, Kiehl M, Hopfer O, Wattad MA, Schimanski CC, Celik C, Pohle T, Ruhe M, Kern WV, Schmitt A, Lorenz HM, Souto-Carneiro M, Gaeddert M, Halama N, Meuer S, Kräusslich HG, Müller B, Schnitzler P, Parthé S, Bartenschlager R, Gronkowski M, Klemmer J, Schmitt M, Dreger P, Kriegsmann K, Schlenk RF, Müller-Tidow C |
2022 | |
|
Convalescent plasma associates with reduced mortality and improved clinical trajectory in patients hospitalized with COVID-19
Shanna A. Arnold Egloff, Angela Junglen, Joseph S Restivo, Marjorie Wongskhaluang, Casey Martin, Pratik Doshi, Daniel Schlauch, Gregg Fromell, Lindsay Sears, Mick Correll, Howard Burris, Charles LeMaistre |
Journal of Clinical Investigation | 2021 |
|
Results of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patients
Sixten Körper, Manfred Weiss, Daniel Zickler, Thomas Wiesmann, Kai Zacharowski, Victor M. Corman, Beate Grüner, Lucas Ernst, Peter Spieth, Philipp M. Lepper, Martin Bentz, Sebastian Zinn, Gregor Paul, Johannes Kalbhenn, Matthias M. Dollinger, Peter Rosenberger, Thomas Kirschning, Thomas Thiele, Thomas Appl, Benjamin Mayer, Michael Schmidt, Christian Drosten, Hinnerk Wulf, Jan Kruse, Bettina Jungwirth, Erhard Seifried, Hubert Schrezenmeier |
Journal of Clinical Investigation | 2021 |
|
A MULTICENTER RANDOMIZED OPEN-LABEL CLINICAL TRIAL FOR CONVALESCENT PLASMA IN PATIENTS HOSPITALIZED WITH COVID-19 PNEUMONIA
Cristina Avendaño-Solá, Antonio Ramos-Martínez, Elena Muñez-Rubio, Belen Ruiz-Antorán, Rosa Malo, Ferran Torres, Ana Fernández-Cruz, Jorge Calderon-Parra, Concepcion Payares-Herrera, Alberto Díaz de Santiago, Irene Romera Martínez, Ilduara Pintos-Pascual, Jaime Lora-Tamayo, Mikel Mancheño-Losa, Maria Liz Paciello Coronel, AL Martinez-Gonzalez, Julia Vidán-Estévez, Maria José Nuñez-Orantos, Maria Isabel Saez-Serrano, Maria Lourdes Porras-Leal, Maria del Castillo Jarilla-Fernández, Paula Villares, Jaime Perez de Oteyza, Ascensión Ramos-Garrido, Lydia Blanco, Maria Elena Madrigal-Sánchez, Martín Rubio-Batllés, Ana Velasco-Iglesias, José Ramón Paño-Pardo, JA Moreno-Chulilla, Eduardo Muñiz-Diaz, Inmaculada Casas, Mayte Pérez-Olmeda, Javier García-Pérez, Jose Alcami, José Luis Bueno, Rafael F. Duarte |
Journal of Clinical Investigation | 2021 |
|
A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumonia
Katharine J. Bar, Pamela A Shaw, Grace H Choi, Nicole Aqui, Andrew Fesnak, Jasper B. Yang, Haideliza Soto-Calderon, Lizette Grajales, Julie Starr, Michelle Andronov, Miranda Mastellone, Chigozie Amonu, Geoff Feret, Maureen DeMarshall, Marie Buchanan, Maria Caturla, James Gordon, Alan Wanicur, M. Alexandra Monroy, Felicity Mampe, Emily Lindemuth, Sigrid Gouma, Anne M Mullin, Holly Barilla, Anastasiya Pronina, Leah Irwin, Raeann Thomas, Risa A. Eichinger, Faye Demuth, Eline T. Luning Prak, Jose L. Pascual, William Short, Michal A. Elovitz, Jillian Baron, Nuala J Meyer, Kathleen O. Degnan, Ian Frank, Scott Hensley, Donald L. Siegel, Pablo Tebas |
Journal of Clinical Investigation | 2021 |
|
Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response
JD Herman, C Wang, C Loos, H Yoon, J Rivera, ME Dieterle, D Haslwanter, RK Jangra, RH Bortz, KJ Bar, B Julg, K Chandran, D Lauffenburger, L Pirofski, G Alter |
Nature Communications | 2021 |
|
The Journal of Clinical Investigation in the time of COVID-19
A Casadevall, S Jackson, GL Semenza, GF Tomaselli, RS Ahima |
Journal of Clinical Investigation | 2021 |
|
Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence
SA Klassen, JW Senefeld, KA Senese, PW Johnson, CC Wiggins, SE Baker, N van Helmond, KA Bruno, L Pirofski, S Shoham, BJ Grossman, JP Henderson, RS Wright, DL Fairweather, NS Paneth, RE Carter, A Casadevall, MJ Joyner |
Frontiers in Medicine | 2021 |
|
Rapid and Successful Implementation of a COVID-19 Convalescent Plasma Programme—The South African Experience
TN Glatt, C Hilton, C Nyoni, A Swarts, R Swanevelder, J Cowley, C Mmenu, T Moyo-Gwete, PL Moore, M Kutama, J Jaza, I Phayane, T Brits, J Koekemoer, U Jentsch, D Nelson, K van den Berg, M Vermeulen |
Viruses | 2021 |
|
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review
V Piechotta, C Iannizzi, KL Chai, SJ Valk, C Kimber, E Dorando, I Monsef, EM Wood, AA Lamikanra, DJ Roberts, Z McQuilten, C So-Osman, LJ Estcourt, N Skoetz |
Cochrane Database of Systematic Reviews | 2021 |
|
Regulatory challenges of convalescent plasma collection during the evolving stages of COVID ‐19 pandemic in the United States
S Hassan, KA West, K ConryCantilena, VD Giorgi |
Transfusion | 2021 |
|
Convalescent plasma use in the USA was inversely correlated with COVID-19 mortality
A Casadevall, Q Dragotakes, PW Johnson, JW Senefeld, SA Klassen, RS Wright, MJ Joyner, N Paneth, RE Carter |
eLife | 2021 |
|
The Effectiveness of Convalescent Plasma for the Treatment of Novel Corona Virus Disease 2019: A Systematic Review and Meta-Analysis
H Cao, L Ming, L Chen, X Zhu, Y Shi |
Frontiers in Medicine | 2021 |
|
Immunological effects of convalescent plasma therapy for coronavirus: a scoping review
B Esmaeili, S Esmaeili, Z Pourpak |
BMC Infectious Diseases | 2021 |
|
Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP)
M Bassetti, DR Giacobbe, P Bruzzi, E Barisione, S Centanni, N Castaldo, S Corcione, FG Rosa, FD Marco, A Gori, A Gramegna, G Granata, A Gratarola, AE Maraolo, M Mikulska, A Lombardi, F Pea, N Petrosillo, D Radovanovic, P Santus, A Signori, E Sozio, E Tagliabue, C Tascini, C Vancheri, A Vena, P Viale, F Blasi, M Bassetti, DR Giacobbe, P Bruzzi, E Barisione, S Centanni, N Castaldo, S Corcione, FG Rosa, FD Marco, A Gori, A Gramegna, G Granata, A Gratarola, AE Maraolo, M Mikulska, A Lombardi, F Pea, N Petrosillo, D Radovanovic, P Santus, A Signori, E Sozio, E Tagliabue, C Tascini, C Vancheri, A Vena, P Viale, F Blasi |
Infectious Diseases and Therapy | 2021 |
|
Efficacy and safety of current treatment interventions for patients with severe COVID‐19 infection: A network meta‐analysis of randomized controlled trials
Q Cheng, G Zhao, J Chen, Q Jia, Z Fang |
Journal of Medical Virology | 2021 |
|
Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
P Bégin, J Callum, E Jamula, R Cook, NM Heddle, A Tinmouth, MP Zeller, G Beaudoin-Bussières, L Amorim, R Bazin, KC Loftsgard, R Carl, M Chassé, MM Cushing, N Daneman, DV Devine, J Dumaresq, DA Fergusson, C Gabe, MJ Glesby, N Li, Y Liu, A McGeer, N Robitaille, BS Sachais, DC Scales, L Schwartz, N Shehata, AF Turgeon, H Wood, R Zarychanski, A Finzi, D Marceau, A Huang, H Carr, Y Lin, R Lall, C Graham, C Arsenault, V Sales, D Sidhu, M Semret, C Hamm, E Arhanchiague, Z Solh, N Srour, K Soliman, C Yee, V Laroche, S Nahirniak, C Greenaway, M Pai, A Côté, JL Tsang, C Cserti-Gazdewich, D Talbot, S Poulin, R Guimaraes, M Rushton-Marovac, A Langlois, S Ning, A Shih, M Boileau, H Singh, D Ledingham, A Ponnampalam, M Yan, O Prokopchuk-Gauk, A Poirier, G Girouard, K Pavenski, O Drouin, D Harris, M Durand, E Rimmer, D Ovakim, F Ménard, G Cuccarolo, J Carruthers, K Lucier, MC Auclair, M Avram, M Brassard, S Cerro, V Martinez, J Morin, M Saint-Jacques, M Veillette, C Armali, A Kron, D Modi, J Duncan, P Justumus, MS John, G St-Onge, M Hadzi-Tosev, PM Dion, L McGillivary, AV de Moulliac, SA Nyman, S Perilli, PJ Vliet, S Lane, K Pavenski, R Pereira, E Sirotich, J Abelson, S Greene, A Khandelwal, S Thakar, S Longo, SP Anand, M Benlarbi, C Bourassa, M Boutin, J Descôteaux-Dinelle, G Gendron-Lepage, G Goyette, A Laumaea, H Medjahed, J Prévost, J Richard, D Kaufmann, E Brunet-Ratnasingham, N Chaumont, M Drebot, A Robinson, E Mendoza, K Dimitrova, K Manguiat, C Phillipson, M Chan, D Evans, J Lin, L Boyer, M Cloutier, M Drouin, É Ducas, N Dussault, MJ Fournier, P Landy, MÈ Nolin, J Perreault, T Tremblay, I Nazy, F Xie, D Liu, M Wong, G Silverio, K Walkus, M Barton, K Haveman, D Mueller, A Scott, M Moher, G Wood, T Roarty, F Auld, G Carney, V Thomson, R Onell, K Walley, K Donohoe, C Brunk, G Hernandez, T Jacobucci, L Lazosky, P Mann, G Raval, LA Zampieri, M Sekhon, A Wright, N James, G Chang, R Chen, K Deol, J Gantioqui, E Larsen, N Ramdin, M Roche, K Rosinski, L Sham, M Storms, M Gillrie, E Mahe, D Suryanarayan, A Ugarte-Torres, T Robinson, M Gibbs, J Hewsgirard, M Holmes, J McCarthy, M Ody, K Doucette, W Sligl, A Sonpar, K Robertson, J Narayan, L Ravindran, B Stewart, L Zapernick, S Lee, E Sy, A Wong, K Gryzb, S Craddock, D Fuchs, D Myrah, S Sunny, SR Harding, S Kogilwaimath, N Hodgson, D Johnson, S Meier, K Thomson, A Heendeniya, B Houston, Y Kenyan, S Lother, K Olafson, B Rush, T Wuerz, D Solvason, L Albensi, S Alias, N Choi, L Curtis, M Hutmacher, H Kashani, D Lane, N Marten, T Pronyk-Ward, L Rigaux, R Silva, Q Tays, R Naidu, J Mathews, M Mai, V Miceli, L Molson, G Radhakrishnan, L Schaefer, M Haddad, S Landry, R Chernish, R Kruisselbrink, T Liu, J Jeromin, A Siddiqui, C Girolametto, K Krokoszynski, C Main, A Fox-Robichaud, B Rochwerg, E Kruja, D Ellingham, D Sampat, N Tang, D Leto, M Karunakaran, D Ricciuto, K Fusco, T Ghate, H Robinson, I Ball, S Shalhoub, M Slessarev, M Silverman, E Nano, T Bentall, E Campbell, J Kinney, S Parvathy, E Fera, AL Delfa, J Nadarajah, H Solow, E Mendoza, K Engel, D Monaco, L Kononow, S Suntharalingam, M Fralick, L Munshi, S Saeed, O Hajjaj, E Hsu, K Ali, E Duan, G Farjou, L Jenson, M Salib, L Patterson, S Anant, J Ding, J Jomy, P Das, A Geagea, S Ingber, E Owen, A Lostun, T Albano, A Chatterjee, M Giraldo, J Hickey, I Lee, N Okada, N Pasquale, R Ponzielli, M Rahmat, S Sabur, M Schlag, L Aguiar, A Damani, S Hong, M Kokabi, C Perkins, J Cowan, T Giulivi, D MacFadden, J Cyr, A Pecarskie, R Porteous, PO Vedder, I Watpool, P Berardi, L Bustani, A Graver, A Iyengar, M Kisilewicz, J Majewski, M Marovac, R Murthy, K Sharma, M Walcer, Z Chagla, J Cheung, E Duan, F Clarke, K Matic, M Giraldo, J Hickey, I Lee, N Okada, N Pasquale, R Ponzielli, M Rahmat, S Sabur, M Schlag, T Carpenter, K Schwartz, P Suthar, A Jiwajee, D Lindsay, A Malik, B Tse, L Matukas, J Ray, S Bell, E Krok, R Guo, S John, V Joshi, J Keen, C Lazongas, J Ostro, K Shore, J Wang, J Choi, P Nallapati, T Irwin, V Wang, P Sheldrake, N Adhikari, H Wunsch, J Bailey, H Meirovich, C Colavecchia, E Kahwash, S Sud, M Romano, B Coburn, LD Sorbo, J Granton, S Husain, J Pendergrast, A Sharkawy, L Wilcox, S Saeed, O Hajjaj, M Kulikova, S Massin, W Kennette, I Mazzetti, K Naccarato, G Park, A Pennetti, C Primeau, C Vilag, Y Lapointe, AS Lemay, E Duceppe, B Rioux-Massé, C Tremblay, P Arlotto, C Bouchard, S Matte, M Messier-Peet, CL Francoeur, F Lauzier, G Leblanc, D Bellemare, È Cloutier, O Costerousse, ÉC Chénard, R Daher, M Daigle, S Grenier, G Guilbeault, MP Rioux, M St-Onge, A Tremblay, B Beaudoin, L Lanthier, P Larrivée, PA Morin, É Carbonneau, R Lacasse, J Autmizguine, I Boucoiran, GD Pont-Thibodeau, AL Haye, V Lague, K Léveillé, C Quach-Thanh, G Émériaud, P Jouvet, É Haddad, C Turgeon-Provost, S Fox, D Baldé, L Ménard, S Morissette, M Schnorr-Meloche, AA Turcotte, C Vallée, S Castonguay, T Nguyen, N Rivest, M Roussos, E Simoneau, A Belecciu, MH Bouchard, E Daviau, C Martin, N Sabourin, S Tremblay, É Gagné, NL Gagné, J Larouche, V Larouche, V Tremblay, V Tremblay, P Blanchette, D Claveau, M Lamarre, D Tapps, M Albert, A Duca, JM Leduc, JS Boudreault-Pedneault, A Barsalou, S Deschênes-Dion, S Ibrahim, S Ridyard, J Rousseau, S Ahern, MP Arsenault, SF Dufresne, L Mollica, HT Wang, S Beau, D Beaupré, M Dégarie, I Delorme, M Farkas, MO Gratton, A Guertin, G Jalbert, M Meilleur, CR Labrecque, É Santos, JT Lu, J Auger, MC Lessard, L Mardini, Y Pesant, L Delves, L Delves, S Denault, S Grigorova, M Lambert, N Langille, C Langlois, C Rock, Y Sardin-Laframboise, P Archambault, J Bélanger-Pelletier, E Duquet-Deblois, V Dupuis-Picard, Y Hamelin, S Leduc, M Richard, M Fortin, P Gervais, MÈ Boulay, C Ferland, J Guertin, J Lepage, A Roy, S Assouline, S Caplan, L Kong, C Canticas, C Mayhew, J Ouedraogo, TS Tep, G Batist, M Cheng, M Klein, N Kronfli, P Pelletier, S Qureshi, D Vinh, R Dziarmaga, H Peiris, K Proulx-Boucher, J Roger, MA Rothschild, CY Yuen, S Barkati, JP Routy, S Sinanan-Pelletier, R LeBlanc, E St-Hilaire, P Thibeault, K Morin, G Caissie, JC Collette, L Daigle, M Daigle, B Gendron, N Godin, A Lapointe, G Moreau, L Ouellette-Bernier, J Rockburn, B Sonier-Ferguson, C Wilson, R DeSimone, G Ellsworth, R Fry, N Goss, R Gulick, C Vaamonde, T Wilkin, C Arar, J Berardi, D Chen, C Garcia-Miller, A Goldbach, L Gripp, D Hayden, K Kane, J Li, KA Marcelin, C Megill, M Nelson, A Paguntalan, G Raab, G Resso, R Rosario, N Rossen, S Tamura, E Zhao, C Goss, Y Kim, E Patel, S Paul, T Romero, N ElBadri, L Flores, T Sandoval, S Kapadia, L Vasovic, SK Griffiths, D Alvarado, F Goudy, M Lewis, M Loizou, R Louie, C Pambrun, S Torrance, S Drews, J McManus, O Cuevas, W Lafresne, P Ruoso, C Shin, T Steed, R Ward, I Allard, M Germain, S Girard, É Parent, CM Pigeon, ME Lopes, M Pêcego, N Rosario, CA da Costa Silva, T Oliveira, MC Lopes, S Mateos, L Hall, S Paradiso, D Strauss, DM Arnold |
Nature Medicine | 2021 |
|
Convalescent plasma for COVID-19: a meta-analysis, trial sequential analysis, and meta-regression
TA Snow, N Saleem, G Ambler, E Nastouli, LE McCoy, M Singer, N Arulkumaran |
British Journal of Anaesthesia | 2021 |
|
COVID-19 Advanced Care
E Fouka, I Kalomenidis, N Gianniou, S Gida, P Steiropoulos |
Journal of Personalized Medicine | 2021 |
|
Anti-SARS-CoV-2 hyperimmune globulin demonstrates potent neutralization and antibody-dependent cellular cytotoxicity and phagocytosis through N and S proteins
JM Díez, C Romero, M Cruz, P Vandeberg, WK Merritt, E Pradenas, B Trinité, J Blanco, B Clotet, T Willis, R Gajardo |
The Journal of Infectious Diseases | 2021 |
|
Prevention and Treatment of SARS-CoV2 Infection in People Living with HIV: The Need for Specific Data
NA Díaz, R de Miguel, F Agüero, O Sued, JR Arribas, J Ambrosioni, J Ambrosioni, JL Blanco, L de la Mora, F García-Alcaide, A González-Cordón, A Inciarte, M Laguno, L Leal, E Martínez-Chamorro, M Martínez-Rebollar, JM Miró, JF Rojas, B Torres, J Mallolas, L Albiac, DL Agüero, M Bodro, C Cardozo, M Chumbita, N García, C García-Vidal, MM Hernández-Meneses, S Herrera, L Linares, A Moreno, L Morata, JA Martínez-Martínez, P Puerta, V Rico, A Soriano, M Martínez, M del Mar Mosquera, MA Marcos, J Vila, M Tuset, D Soy, A Vilella, A Almuedo, MJ Pinazo, J Muñoz |
Infectious Diseases and Therapy | 2021 |
|
Efficacy of COVID-19 Treatments: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
C Zhang, H Jin, YF Wen, G Yin |
Frontiers in public health | 2021 |
|
Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis
RA Siemieniuk, JJ Bartoszko, JP Martinez, E Kum, A Qasim, D Zeraatkar, A Izcovich, S Mangala, L Ge, MA Han, T Agoritsas, D Arnold, C Ávila, DK Chu, R Couban, E Cusano, AJ Darzi, T Devji, F Foroutan, M Ghadimi, A Khamis, F Lamontagne, M Loeb, A Miroshnychenko, S Motaghi, S Murthy, RA Mustafa, G Rada, B Rochwerg, C Switzer, PO Vandvik, RW Vernooij, Y Wang, L Yao, GH Guyatt, R Brignardello-Petersen |
BMJ (Clinical research ed.) | 2021 |
|
Early high antibody-titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma
T Devos, QV Thillo, V Compernolle, T Najdovski, M Romano, N Dauby, L Jadot, M Leys, E Maillart, S Loof, L Seyler, M Moonen, M Moutschen, NV Regenmortel, KK Ariën, C Barbezange, A Betrains, M Garigliany, MM Engelen, I Gyselinck, P Maes, A Schauwvlieghe, L Liesenborghs, A Belmans, P Verhamme, G Meyfroidt |
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology | 2021 |
|
Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials
C Axfors, P Janiaud, AM Schmitt, J vant Hooft, ER Smith, NA Haber, A Abayomi, M Abduljalil, A Abdulrahman, Y Acosta-Ampudia, M Aguilar-Guisado, F Al-Beidh, MM Alejandria, RN Alfonso, M Ali, M AlQahtani, A AlZamrooni, JM Anaya, MA Ang, IF Aomar, LE Argumanis, A Averyanov, VP Baklaushev, O Balionis, T Benfield, S Berry, N Birocco, LB Bonifacio, AC Bowen, A Bown, C Cabello-Gutierrez, B Camacho, A Camacho-Ortiz, S Campbell-Lee, DH Cao, A Cardesa, JM Carnate, , R Cavallo, FR Chowdhury, FU Chowdhury, G Ciccone, A Cingolani, FM Climacosa, V Compernolle, CF Cortez, AC Neto, S DAntico, J Daly, F Danielle, JS Davis, FG Rosa, JT Denholm, CM Denkinger, D Desmecht, JC Díaz-Coronado, JA Ponce-Medrano, AF Donneau, TE Dumagay, S Dunachie, CC Dungog, O Erinoso, IM Escasa, LJ Estcourt, A Evans, AL Evasan, CJ Fareli, V Fernandez-Sanchez, C Galassi, JE Gallo, PJ Garcia, PL Garcia, JA Garcia, M Garigliany, E Garza-Gonzalez, DT Gauiran, PA García, JA Giron-Gonzalez, D Gómez-Almaguer, AC Gordon, A Gothot, JS Guaqueta, C Green, D Grimaldi, NE Hammond, H Harvala, FM Heralde, J Herrick, AM Higgins, TE Hills, J Hines, K Holm, A Hoque, E Hoste, JM Ignacio, AV Ivanov, M Janssen, JH Jennings, V Jha, RA King, J Kjeldsen-Kragh, P Klenerman, A Kotecha, F Krapp, L Labanca, E Laing, M Landin-Olsson, PF Laterre, LL Lim, J Lim, O Ljungquist, JM Llaca-Díaz, C López-Robles, S López-Cárdenas, I Lopez-Plaza, JA Lucero, M Lundgren, J Macías, SC Maganito, AF Malundo, RD Manrique, PM Manzini, M Marcos, I Marquez, FJ Martínez-Marcos, AM Mata, CJ McArthur, ZK McQuilten, BJ McVerry, DK Menon, G Meyfroidt, MA Mirasol, B Misset, JS Molton, AV Mondragon, DM Monsalve, PM Choghakabodi, SC Morpeth, PR Mouncey, M Moutschen, C Müller-Tidow, E Murphy, T Najdovski, AD Nichol, H Nielsen, RM Novak, MV OSullivan, J Olalla, A Osibogun, B Osikomaiya, S Oyonarte, JM Pardo-Oviedo, MC Patel, DL Paterson, CA Peña-Perez, AA Perez-Calatayud, E Pérez-Alba, A Perkina, N Perry, M Pouladzadeh, I Poyato, DJ Price, AK Quero, M Rahman, S Rahman, M Ramesh, C Ramírez-Santana, M Rasmussen, MA Rees, E Rego, JA Roberts, DJ Roberts, Y Rodríguez, J Rodríguez-Baño, BA Rogers, M Rojas, A Romero, KM Rowan, F Saccona, M Safdarian, MC Santos, J Sasadeusz, G Scozzari, M Shankar-Hari, G Sharma, T Snelling, A Soto, PY Tagayuna, A Tang, G Tatem, L Teofili, SY Tong, AF Turgeon, JD Veloso, B Venkatesh, Y Ventura-Enriquez, SA Webb, L Wiese, C Wikén, EM Wood, GM Yusubalieva, K Zacharowski, R Zarychanski, N Khanna, D Moher, SN Goodman, JP Ioannidis, LG Hemkens |
BMC Infectious Diseases | 2021 |
|
Convalescent Plasma for Patients Hospitalized With Coronavirus Disease 2019: A Meta-Analysis With Trial Sequential Analysis of Randomized Controlled Trials
RR Ling, JJ Sim, FL Tan, BC Tai, N Syn, SS Mucheli, BE Fan, S Mitra, K Ramanathan |
Transfusion Medicine Reviews | 2021 |
|
Characteristics of published/registered clinical trials on COVID-19 treatment: A systematic review
P Asili, M Mirahmad, O Tabatabaei-Malazy, A Manayi, E Haghighat, M Mahdavi, B Larijani |
DARU Journal of Pharmaceutical Sciences | 2021 |
|
Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients With COVID-19 Pneumonia: A Randomized Clinical Trial
F Menichetti, P Popoli, M Puopolo, SS Alegiani, G Tiseo, A Bartoloni, GV Socio, S Luchi, P Blanc, M Puoti, E Toschi, M Massari, L Palmisano, G Marano, M Chiamenti, L Martinelli, S Franchi, C Pallotto, LR Suardi, BL Pasqua, M Merli, P Fabiani, L Bertolucci, B Borchi, S Modica, S Moneta, G Marchetti, A dArminio Monforte, L Stoppini, N Ferracchiato, S Piconi, C Fabbri, E Beccastrini, R Saccardi, A Giacometti, S Esperti, P Pierotti, L Bernini, C Bianco, S Benedetti, A Lanzi, P Bonfanti, M Massari, S Sani, A Saracino, A Castagna, L Trabace, M Lanza, D Focosi, A Mazzoni, M Pistello, M Falcone, R Palazzolo, S Casari, A Occhionero, T Grazzini, DL Silvestri, M Iorio, A Tosti, D Francisci, C Becattini, M Pirro, M Marchesi, S Bastianelli, S Pierucci, C Busti, A Mencacci, S Bozza, B Camilloni, V Annoni, C Bellotto, A Cioppi, G Querci, G Ciusa, M Tassara, A Danise, S Chigiotti, G Morelli, M Meini, V Galfo, S Ferranti, E Tagliaferri, R Iapoce, C Barbieri, A Forniti, C Caroselli, S Verdenelli, F Monzani, P Mazzetti, G Moscato, F Barchiesi, M Andreotti, F Baldanti, A Binelli, MR Capobianchi, RD Cas, DD Sevo, P Fazi, C Gasparrini, I Ippoliti, A Mancino, FM Ippolito, F Paoloni, P Ruggeri, A Rughini, E Salvi, V Sargentini, MP Trotta, M Vignetti |
2021 | |
|
CONVALESCENT plasma for COVID‐19: A meta‐analysis of clinical trials and real‐world evidence
C Kloypan, M Saesong, J Sangsuemoon, P Chantharit, P Mongkhon |
European Journal of Clinical Investigation | 2021 |
|
Management of COVID patients with convalescent plasma: Do we have the final word?
F Menichetti, M Falcone, G Tiseo |
European Journal of Internal Medicine | 2021 |
|
Systematic review and meta‐analysis of randomised controlled trials testing the safety and efficacy of convalescent plasma in the treatment of coronavirus disease 2019 ( COVID ‐19): Evidence‐base for practise and implications for research
T Gupta, S Kannan, B Kalra, P Thakkar |
Transfusion Medicine | 2021 |
|
Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients: A Randomized Clinical Trial
MB Ortigoza, H Yoon, KS Goldfeld, AB Troxel, JP Daily, Y Wu, Y Li, D Wu, GF Cobb, G Baptiste, M OKeeffe, MO Corpuz, L Ostrosky-Zeichner, A Amin, IM Zacharioudakis, DT Jayaweera, Y Wu, JV Philley, MS Devine, MS Desruisseaux, AD Santin, S Anjan, R Mathew, B Patel, M Nigo, R Upadhyay, T Kupferman, AN Dentino, R Nanchal, CA Merlo, DN Hager, K Chandran, JR Lai, J Rivera, CR Bikash, G Lasso, TP Hilbert, M Paroder, AA Asencio, M Liu, E Petkova, A Bragat, R Shaker, DD McPherson, RL Sacco, MJ Keller, CR Grudzen, JS Hochman, L Pirofski, FZ Rahman, AO Ajayi, SL Rodriguez, AG Ledesma, D Keeling, N Rappoport, SF Ebel, J Kim, M Chang, K Chan, P Patel, A Martocci, S Dave, Y Darwish, M Taveras, V Shoyelu, P Xin, E Iturrate, LC Moldolsky, BJ Raimondo, S Mendez, P Hughes, S Sterling, A S, S Yaghi, K Veloso, M Sheikh, E Visconti-Ferrara, A Fleming, H Youn, BJ Fran, R Medina, R McKell, S Khan, T Hamilton, CJ Sanchez, NH Patel, L Cleare, O Vergnolle, A Nakouzi, G Quevedo, RH Bortz, AS Wirchnianski, C Florez, R Babb, J Ayala, KZ Tsagaris, A James, I Eke, A Obeidallah, OA Sandu, S Sohval, L Serrano-Rahman, J Uehlinger, R Bartash, A Al-Abduladheem, I Gendlina, C Sheridan, A Bortnick, J Eichler, R Kaufman, S Yukelis, M Pennock, M Goggin, C Shen, J Annam, A Khokhar, D Barboto, BJ Lally, A Lee, M Lee, XA Yang, S Allen, A Malaviya, O Moussa, R Park, R Sample, A Bae, G Benoni, LL Boerger, LD Baker, MA Luther, LS Ameti, N Briggs, MR Golden, M Gormally, GS Huang, RM Johnson, AR Morrison, M Montagna-Hill, BN Rivera, GM Cortezzo, KB Debski, Nicoletti, K DeBenedictis, R Davis, C Marshall, MA Cuartas, L Beauchamps, J Bertran-Lopez, JG Zamora, M Delgado-Lelievre, S Dominguez, CC Lee, H Kusack, V Karakeshishyan, A Hajaz, D Deniz, G Garcia, K Dae, P Blenet, D Jaffe, L Olson, D Sabogal, O Blust, VD Perez, C Bornia, V Rodriguez-Perez, V Calderon, R Ramdev, A Jolly, I Guzman, R Guerra, S Brito, R Hobbs, R Denham, J Dick, MD Hernandez, LE Nielsen, SM Anjum, SC Mader, TP Stutz, M Mammadova, P Nichols, TS Khan, MR Boktour, BL Castaneda, BD Benitez, E Hinojosa, BC Guerra, A Ortiz, RS Hebbeler-Clark, PJ McShane, R Hibbard, BE Hawkins, ER Dohanich, C Wadle, KL Greenlee, J Brooks, CD Herrick, A Gode, P Bergl, K Hu, J Patel, S Srinivasan, J Graf, C Klis, K Reimer, E Carpenter, C Naczek, R Petersen, R Dex, J Drossart, J Zelten, C Brummitt, M Liang, L Yanny, G Dennison, P Runningen, B Brzezinski, S Fiebig, C Naczek, M Kasdorf, L Parameswaran, AT Corcoran, A Rohatgi, MW Wronska, X Wu, R Srinivasan, FM Deng, TD Filardo, J Pendse, SB Blaser, O Whyte, JM Gallagher, OE Thomas, D Ramos, CL Sturm-Reganato, CC Fong, IM Daus, AG Payoen, JT Chiofolo, MT Friedman, DW Wu, JL Jacobson, JG Schneider, UN Sarwar, HE Wang, RM Huebinger, G Dronavalli, Y Bai, CZ Grimes, KW Eldin, VE Umana, JG Martin, TR Heath, FO Bello, DL Ransford, M Laurent-Rolle, SV Shenoi, OB Akide-Ndunge, B Thapa, JL Peterson, K Knauf, SU Patel, LL Cheney, CA Tormey, JE Hendrickson |
JAMA internal medicine | 2021 |
|
Passive immune therapies: another tool against COVID-19
L Estcourt |
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program | 2021 |
|
COVID-19 convalescent plasma
Tobian AA, Cohn CS, Shaz BH |
Blood | 2021 |
|
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
|
2021 | |
|
Responses to a neutralizing monoclonal antibody for hospitalized patients with COVID-19 according to baseline antibody and antigen levels: A randomized controlled trial
|
Annals of internal medicine | 2021 |
|
Antibody Attributes that Predict the Neutralization and Effector Function of Polyclonal Responses to SARS-CoV-2.
Natarajan H, Xu S, Crowley AR, Butler SE, Weiner JA, Bloch EM, Littlefield K, Benner SE, Shrestha R, Ajayi O, Wieland-Alter W, Sullivan D, Shoham S, Quinn TC, Casadevall A, Pekosz A, Redd AD, Tobian AAR, Connor RI, Wright PF, Ackerman ME |
medRxiv : the preprint server for health sciences | 2021 |
|
Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma.
Sullivan DJ, Gebo KA, Shoham S, Bloch EM, Lau B, Shenoy AG, Mosnaim GS, Gniadek TJ, Fukuta Y, Patel B, Heath SL, Levine AC, Meisenberg BR, Spivak ES, Anjan S, Huaman MA, Blair JE, Currier JS, Paxton JH, Gerber JM, Petrini JR, Broderick PB, Rausch W, Cordisco ME, Hammel J, Greenblatt B, Cluzet VC, Cruser D, Oei K, Abinante M, Hammitt LL, Sutcliffe CG, Forthal DN, Zand MS, Cachay ER, Raval JS, Kassaye SG, Foster EC, Roth M, Marshall CE, Yarava A, Lane K, McBee NA, Gawad AL, Karlen N, Singh A, Ford DE, Jabs DA, Appel LJ, Shade DM, Ehrhardt S, Baksh SN, Laeyendecker O, Pekosz A, Klein SL, Casadevall A, Tobian AAR, Hanley DF |
medRxiv : the preprint server for health sciences | 2021 |
|
Convalescent Plasma Use in the United States was inversely correlated with COVID-19 Mortality: Did Plasma Hesitancy cost lives?
Casadevall A, Dragotakes Q, Johnson PW, Senefeld JW, Klassen SA, Wright RS, Joyner MJ, Paneth N, Carter RE |
2021 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)